Clinical News

Adding Value to Oncology Practice Accreditation: Community Oncology Alliance Works with the Commission on Cancer

Gail Thompson

September 2015, Vol 5, No 6 - Practice Accreditation

Attendees at the 2015 Association for Value-Based Cancer Care conference heard Robert “Bo” Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance (COA), describe recent accreditation initiatives for the oncology medical home (OMH) model. The movement toward formalization of the [ Read More ]

Jakafi (Ruxolitinib): First FDA-Approved Medication for the Treatment of Patients with Polycythemia Vera

Lisa A. Raedler, PhD, RPh

June 2015, Vol 5, No 5 - Drug Update

Similar to myelofibrosis and essential thrombocythemia, polycythemia vera is a Philadelphia chromosome–negative myeloproliferative neoplasm.1 Polycythemia vera is characterized by the clonal stem-cell proliferation of red blood cells, white blood cells, and platelets.2,3 Increased red blood cell mass results in the [ Read More ]